Abbott Laboratories hit a new 52-week high, surpassing its previous peak of $136.99, which the company achieved on February ...

Abbott Laboratories (ABT) sees mixed momentum as shares dip after gains. Analysts highlight strong demand, low debt, and ...

Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to ...

In this article, we will take a look into Abbott Laboratories's (NYSE:ABT) DCF analysis, a reliable and data-driven approach ...

Abbott Laboratories's ABT short percent of float has risen 21.7% since its last report. The company recently reported that it ...

Gregg LoCascio, Michael Glick, Tracie Bryant and their team at Kirkland & Ellis secured a defense verdict in California state ...

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Strategic Financial Concepts LLC purchased a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The ...

Abbott Laboratories (NYSE:ABT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Wednesday. Several other ...

According to Benzinga Pro, Abbott Laboratories's peer group average for short interest as a percentage of float is 3.78%, which means the company has less short interest than most of its peers. Did ...

Shares of Abbott Laboratories ABT rallied 1.50% to $132.13 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.24% to ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...